Valuation | Industry Range | |
---|---|---|
Price / Earnings | N/A | |
Book Value | 0.08 |   |
Earnings Per Share | -$0.35 |   |
Price To Sales Ratio | 85.71 |   |
Price To Book Ratio | 131.71 |   |
Price To Tangible Book Ratio | 131.80 |   |
Price/Cash Flow Ratio | N/A | |
Price/Free Cash Flow Ratio | N/A |
Profile | Industry Range | |
---|---|---|
Market Capitalization | 68.3M |   |
Float (MRQ) | 90.96% |   |
Shares Outstanding (MRQ) | 244.2M |   |
Short Interest as a % of Float (MRQ) | 8.71% |   |
Shares Held By Institutions (MRQ) | 57.8M |   |
Margins | Industry Range | |
---|---|---|
Sales | $8.4M |   |
Gross Margin | 85.60% |   |
Net Profit Margin | -981.52% |   |
EBIT Margin | -983.23% |   |
EBITDA Margin | -966.26% |   |
Operating Margins | -983.23% |   |
All fundamentals are Trailing Twelve Months (TTM) unless noted. Preliminary data is based on the company's 8-K
statement or press releases. MRQ = Most Recent Quarter
Financial Strength | Industry Range | |
---|---|---|
Current Ratio (MRQ) | 1.54 |   |
Quick Ratio (MRQ) | 1.54 |   |
Total Debt/Equity Ratio (MRQ) | 3,100.65 |   |
Debt/Common Equity Ratio (MRQ) | 3,100.65 |   |
Effectiveness | Industry Range | |
---|---|---|
Return on Equity | -429.24% |   |
Return on Assets | -169.91% |   |
Asset Turnover | 0.17 |   |
Receivables Turnover | 2.17 |   |
Inventory Turnover | N/A |
Earnings and Dividends | Industry Range | |
---|---|---|
EPS Growth Annual | -22.22% |   |
Dividend Yield 5 Year Average | 0.00% |   |
Current Dividend Yield | 0.00% |   |
Current Payout Ratio | N/A |
*ATHX does not pay a dividend. The average dividend yield for companies in the Biotechnology industry is 1.40%